Related Experiment Video
Updated: Jul 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown
Rosa Puca1, Lavinia Nardinocchi, Hilah Gal
1Molecular Oncogenesis Laboratory and Preclinical Experimental Laboratory, Regina Elena Cancer Institute, Rome, Italy.
Abstract:
About half of cancers sustain mutations in the TP53 gene, whereas the other half maintain a wild-type p53 (wtp53) but may compromise the p53 response because of other alterations. Homeodomain-interacting protein kinase-2 (HIPK2) is a positive regulator of p53 oncosuppressor function. Here, we show, by microarray analysis, that wtp53 lost the target gene activation following stable knockdown of HIPK2 (HIPK2i) in colon cancer cell line. Our data show that the stable knockdown of HIPK2 led to wtp53 misfolding, as detected by p53 immunoprecipitation with conformation-specific antibodies, and that p53 protein misfolding impaired p53 DNA binding and transcription of target genes. We present evidence that zinc supplementation to HIPK2i cells increased p53 reactivity to conformation-sensitive PAb1620 (wild-type conformation) antibody and restored p53 sequence-specific DNA binding in vivo and transcription of target genes in response to Adriamycin treatment. Finally, combination of zinc and Adriamycin suppressed tumor growth in vivo and activated misfolded p53 that induced its target genes in nude mice tumor xenografts derived from HIPK2i cells. Bioinformatics analysis of microarray data from colon cancer patients showed significant association of poor survival with low HIPK2 expression only in tumors expressing wtp53. These results show a critical role of HIPK2 in maintaining the transactivation activity of wtp53 and further suggest that low expression of HIPK2 may impair the p53 function in tumors harboring wtp53.
Insights
Homeodomain-interacting protein kinase-2 (HIPK2) is crucial for wild-type p53 (wtp53) function. Low HIPK2 causes wtp53 misfolding, impairing its tumor-suppressing activity, but zinc can restore function.
Area of Science:
- Molecular Biology
- Cancer Research
- Oncology
Background:
- TP53 gene mutations occur in about half of all cancers.
- Wild-type p53 (wtp53) function can be compromised by other alterations.
- Homeodomain-interacting protein kinase-2 (HIPK2) positively regulates p53's tumor-suppressing activity.
Purpose of the Study:
- To investigate the role of HIPK2 in maintaining wtp53 transactivation activity.
- To explore the impact of HIPK2 knockdown on wtp53 function and conformation.
- To evaluate the therapeutic potential of zinc supplementation in restoring wtp53 activity.
Main Methods:
- Microarray analysis to assess target gene activation in HIPK2-knockdown cells.
- p53 immunoprecipitation with conformation-specific antibodies to detect misfolding.
- In vivo and in vitro experiments using zinc supplementation and Adriamycin treatment.
- Bioinformatics analysis of colon cancer patient data.
Main Results:
- Stable knockdown of HIPK2 (HIPK2i) led to wtp53 misfolding, impairing DNA binding and target gene transcription.
- Zinc supplementation restored wtp53 conformation, DNA binding, and transcription in HIPK2i cells.
- Combination therapy with zinc and Adriamycin suppressed tumor growth in vivo.
- Low HIPK2 expression in wtp53-expressing colon tumors is associated with poor patient survival.
Conclusions:
- HIPK2 plays a critical role in maintaining the transactivation activity of wtp53.
- HIPK2 deficiency leads to wtp53 misfolding and loss of tumor-suppressive function.
- Zinc supplementation represents a potential therapeutic strategy to restore wtp53 function in HIPK2-deficient cancers.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
